Close

Synovial sarcomas

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Overview

Synovial sarcoma is a very rare soft tissue sarcoma with a morbidity of 1 to 3 per million and is diagnosed more often in people younger than 30. The cancerous tumor usually arises from soft tissues near the knee or other joints, mainly in the four limbs and can spread to other areas of the body, like the kidney and lung, especially the lymph nodes. People still do not known what kinds of cells this disease originates from. The reason causes synovial sarcoma is unclear, but researches have linked it to genetics.

Signs, symptoms and treatments

Synovial sarcoma tumor is usually to develop with a low growth rate, and people may not notice it germination for a long time until it causes signs and symptoms like moving problems near the affected areas. In more serious situation, patient feels pain if the tumor invaded site has lots of nerves around. Generally, surgery can remove small size tumor, while a combination of surgery, radiation therapy and/or chemotherapy will be carried out if the synovial sarcoma has develop into a serious situation.

Loading...
Products
Global Services
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.